Results 261 to 270 of about 1,415,935 (292)

IL-17-neutralizing antibody mitigates functional and structural changes in cigarette smoke-induced COPD model. [PDF]

Front Immunol
Riani Moreira A, Uchoa da Silva C, de Paula Costa Mattos L, Jesus Simão J, Camargo Berti V, Henrique Vasconcelos Alves L, Ferreira da Silva A, Jesus Lima F, Karoline Moreira Bezerra S, Nascimento Silva C, Cardoso Allonso-Vale MI, de Fatima Lopes Calvo Tiberio I, Maria Almeida F, Degobbi Tenorio Quirino Dos Santos Lopes F.   +13 more
europepmc   +1 more source

Elevated serum levels of IL-6 and IL-17 may associate with the development of ankylosing spondylitis.

, 2015
Wei Liu, WU Yuan-hao, Lei Zhang, Xiaoya Liu, Bin Xue, Yi Wang, Bin Liu, Qiao Jiang, Hou-Wen Kwang, Dong-Jing Wu   +9 more
openalex   +1 more source

Secukinumab-induced Crohn's disease in a psoriasis patient: a case report highlighting paradoxical reactions to IL-17 inhibition. [PDF]

Front Immunol
Dai H, Xu C, Wang Y, Wu K, Zhang Y, Ge H, Wu Y.   +6 more
europepmc   +1 more source

The dual role of IL-17 in periodontitis regulating immunity and bone homeostasis. [PDF]

Front Immunol
Tang Z, Jin L, Yang Y.
europepmc   +1 more source

The role of IL-17-related signaling in myelomagenesis, disease prognosis/progression, and therapeutic approach-a scoping review. [PDF]

Clin Exp Med
Kulig P, Rałowiec A, Baumert B, Machaliński B.   +3 more
europepmc   +1 more source

Association of vaginal IL-4, IL-6, IL-8, IL-17, IFN-γ, and dietary intake with IBD status and vaginal microbiota in pregnant individuals. [PDF]

PLoS One
Vargas-Robles D, Yap YR, Singha B, Tien J, Purandare M, Rojas-Correa M, Madziar C, Picker M, Dumont T, Leftwich HK, Frisard CF, Ward DV, Peter I, Olendzki B, Maldonado-Contreras A.   +14 more
europepmc   +1 more source

Correction to: KRAS regulates IL-17 signal activity by affect the metastasis of osteosarcoma via an IL-17A-dependent manner. [PDF]

JBMR Plus
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

IL-17 for therapy

Journal of Dermatological Science, 2017
The cytokine IL-17 is now a target for an array of therapeutic monoclonal antibodies supposed to treat a variety of inflammatory diseases. The forerunner Secukinumab, an IL-17A neutralizing antibody, is meanwhile approved as first-line treatments for moderate-to-severe plaque psoriasis, and as second-line treatment for psoriatic arthritis and ...
Florian C, Kurschus, Sonja, Moos
openaire   +2 more sources

IL-17 cytokine family

Journal of Allergy and Clinical Immunology, 2004
A new family of cytokines, IL-17, has recently been defined that reveals a distinct ligand-receptor signaling system. Functional studies have provided evidence for its importance in the regulation of immune responses. Notably, 3 members, IL-17A, IL-17E (IL-25), and IL-17F, have been best characterized both in vitro and in vivo , and have been shown to ...
Mio, Kawaguchi, Mitsuru, Adachi, Naruhito, Oda, Fumio, Kokubu, Shau-Ku, Huang   +4 more
openaire   +2 more sources

IL-17 in human asthma

Expert Review of Respiratory Medicine, 2012
Asthma is perceived as a heterogeneous disease with several clinical phenotypes and triggering factors. In general, cytokines from T-helper 2 cells are believed to be critical contributors of asthma. In recent years, IL-17, another T-helper lymphocyte-associated cytokine, has been put forward as another potentially important mediator of asthma ...
Elin, Silverpil, Anders, Lindén
openaire   +2 more sources